Home NDC 0310-0640 KOSELUGO
Product NDC 0310-0640
11-digit product format 003100640
Labeler code 0310
Product ID 0310-0640_b3809b9c-c5d0-44c6-9c21-abcc230f64ac
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name SELUMETINIB
Dosage form GRANULE
Route ORAL
Labeler AstraZeneca Pharmaceuticals LP
Application NDA219943
Marketing category NDA
Marketing start 2025-09-10
Substance SELUMETINIB
Active strength 7.5 mg/1
Pharmacologic classes Kinase Inhibitor [EPC], Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA], Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219943-001 KOSELUGO SELUMETINIB SULFATE EQ 5MG BASE GRANULE / ORAL RLD, RS 2025-09-10 N219943-002 KOSELUGO SELUMETINIB SULFATE EQ 7.5MG BASE GRANULE / ORAL RLD 2025-09-10
Orange Book patents# Current patent rows page 1 of 1 · 8 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N219943-001 8178693 2026-03-13 Drug substance, Drug product 2025-09-30 N219943-001 9156795 2026-12-12 Drug substance, Drug product 2025-09-30 N219943-001 9562017 2026-12-12 U-4357 Drug substance 2025-09-30 N219943-001 7425637 2028-03-13 Drug substance 2025-09-30 N219943-002 8178693 2026-03-13 Drug substance, Drug product 2025-09-30 N219943-002 9156795 2026-12-12 Drug substance, Drug product 2025-09-30 N219943-002 9562017 2026-12-12 U-4357 Drug substance 2025-09-30 N219943-002 7425637 2028-03-13 Drug substance 2025-09-30
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 8 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219943-001 KOSELUGO EQ 5MG BASE GRANULE / ORAL RLD 2025-09-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219943-002 KOSELUGO EQ 7.5MG BASE GRANULE / ORAL RLD, RS 2025-09-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219943-001 KOSELUGO EQ 5MG BASE GRANULE / ORAL RLD 2025-09-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219943-002 KOSELUGO EQ 7.5MG BASE GRANULE / ORAL RLD, RS 2025-09-10 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219943-001 KOSELUGO EQ 5MG BASE GRANULE / ORAL RLD, RS 2025-09-10 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219943-002 KOSELUGO EQ 7.5MG BASE GRANULE / ORAL RLD 2025-09-10 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219943-001 8178693 2026-03-13 Drug substance, Drug product 2025-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219943-001 9156795 2026-12-12 Drug substance, Drug product 2025-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219943-001 9562017 2026-12-12 U-4357 Drug substance 2025-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219943-001 7425637 2028-03-13 Drug substance 2025-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219943-002 8178693 2026-03-13 Drug substance, Drug product 2025-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219943-002 9156795 2026-12-12 Drug substance, Drug product 2025-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219943-002 9562017 2026-12-12 U-4357 Drug substance 2025-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219943-002 7425637 2028-03-13 Drug substance 2025-09-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219943-001 7425637 2026-03-13 Drug substance 2025-09-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219943-001 8178693 2026-03-13 Drug substance, Drug product 2025-09-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219943-001 9156795 2026-12-12 Drug substance, Drug product 2025-09-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219943-001 9562017 2026-12-12 U-4274 Drug substance 2025-09-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219943-002 7425637 2026-03-13 Drug substance 2025-09-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219943-002 8178693 2026-03-13 Drug substance, Drug product 2025-09-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219943-002 9156795 2026-12-12 Drug substance, Drug product 2025-09-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219943-002 9562017 2026-12-12 U-4274 Drug substance 2025-09-30 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219943-001 8178693 2026-03-13 Drug substance, Drug product 2025-09-30 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219943-001 9156795 2026-12-12 Drug substance, Drug product 2025-09-30 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219943-001 9562017 2026-12-12 U-4357 Drug substance 2025-09-30 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219943-001 7425637 2028-03-13 Drug substance 2025-09-30 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219943-002 8178693 2026-03-13 Drug substance, Drug product 2025-09-30 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219943-002 9156795 2026-12-12 Drug substance, Drug product 2025-09-30 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219943-002 9562017 2026-12-12 U-4357 Drug substance 2025-09-30 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219943-002 7425637 2028-03-13 Drug substance 2025-09-30 a50c72e98297…
Observed Orange Book exclusivity history# Additional Listing Data#
Finished product Yes
Brand name base KOSELUGO
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength SELUMETINIB 7.5 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 6UH91I579U Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 8 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2289418 Internal RxNorm lookup 2289424 Internal RxNorm lookup 2289426 Internal RxNorm lookup 2289428 Internal RxNorm lookup 2723653 Internal RxNorm lookup 2723657 Internal RxNorm lookup 2723659 Internal RxNorm lookup 2723661 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0310-0640-60 KOSELUGO 60 in 1 BOTTLE GRANULE 60 16
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 0310-0640-60 00310064060 60 GRANULE in 1 BOTTLE (0310-0640-60) 60 granule 2025-09-10 No No Current